Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study
Finn Ole Larsen, Alice Markussen, Laura V Diness, Dorte Nielsen
Dyk ned i forskningsemnerne om 'Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study'. Sammen danner de et unikt fingeraftryk.